Table 2

Change in QOL and symptom severity scores according to presence or absence of atrial fibrillation recurrence >30 s

AllP-valueaRecurrentP-valueaNon-recurrentP-valueaP-valueb
AFEQT(n) Mean ± SD(n) Mean ± SD(n) Mean ± SD
Baseline(225) 55.28 ± 22.78<0.001(120) 51.91 ± 22.35<0.001(93) 59.44 ± 22.76<0.001
12-month(192) 82.93 ± 19.53(110) 75.41 ± 21.75(82) 92.73 ± 9.76
Δ (12 month-Baseline)(189) 27.77 ± 24.13(107) 23.68 ± 24.99(82) 33.09 ± 21.990.008
PCS
Baseline(220) 43.03 ± 11.82<0.001(116) 42.83 ± 12.27<0.001(92) 43.54 ± 11.27<0.001
12-month(192) 49.34 ± 10.16(110) 46.93 ± 11.30(82) 52.58 ± 7.29
Δ (12 month-Baseline)(185) 6.19 ± 11.00(104) 4.09 ± 11.13(81) 8.89 ± 10.300.003
MCS
Baseline(220) 43.67  ± 12.94<0.001(116) 42.34 ± 13.34<0.001(92) 45.21 ± 12.64<0.001
12-month(192) 50.24 ± 11.58(110) 48.20 ± 12.20(82) 52.98 ± 10.15
Δ (12 month-Baseline)(185) 6.78 ± 13.74(104) 5.79 ± 15.25(81) 8.05 ± 11.470.26
CCS-SAF
Baseline(226) 2.30 ± 1.13<0.001(123) 2.35 ± 1.14<0.001(91) 2.22 ± 1.12<0.001
12-month(196) 0.67 ± 1.10(114) 1.11 ± 1.24(82) 0.06 ± 0.36
Δ (12 month-Baseline)(194) −1.60 ± 1.48(113) −1.23 ± 1.59(81) −2.10 ± 1.12<0.001
AllP-valueaRecurrentP-valueaNon-recurrentP-valueaP-valueb
AFEQT(n) Mean ± SD(n) Mean ± SD(n) Mean ± SD
Baseline(225) 55.28 ± 22.78<0.001(120) 51.91 ± 22.35<0.001(93) 59.44 ± 22.76<0.001
12-month(192) 82.93 ± 19.53(110) 75.41 ± 21.75(82) 92.73 ± 9.76
Δ (12 month-Baseline)(189) 27.77 ± 24.13(107) 23.68 ± 24.99(82) 33.09 ± 21.990.008
PCS
Baseline(220) 43.03 ± 11.82<0.001(116) 42.83 ± 12.27<0.001(92) 43.54 ± 11.27<0.001
12-month(192) 49.34 ± 10.16(110) 46.93 ± 11.30(82) 52.58 ± 7.29
Δ (12 month-Baseline)(185) 6.19 ± 11.00(104) 4.09 ± 11.13(81) 8.89 ± 10.300.003
MCS
Baseline(220) 43.67  ± 12.94<0.001(116) 42.34 ± 13.34<0.001(92) 45.21 ± 12.64<0.001
12-month(192) 50.24 ± 11.58(110) 48.20 ± 12.20(82) 52.98 ± 10.15
Δ (12 month-Baseline)(185) 6.78 ± 13.74(104) 5.79 ± 15.25(81) 8.05 ± 11.470.26
CCS-SAF
Baseline(226) 2.30 ± 1.13<0.001(123) 2.35 ± 1.14<0.001(91) 2.22 ± 1.12<0.001
12-month(196) 0.67 ± 1.10(114) 1.11 ± 1.24(82) 0.06 ± 0.36
Δ (12 month-Baseline)(194) −1.60 ± 1.48(113) −1.23 ± 1.59(81) −2.10 ± 1.12<0.001

AFEQT, Atrial Fibrillation Effect on QualiTy-of-life; CCS_SAF, Canadian Cardiovascular Society Severity in Atrial Fibrillation; MCS, mental component score; PCS, physical component score.

a

P-value of difference between baseline and 12-months.

b

P-value of difference between recurrent and non-recurrent.

c

Δ (12 month-baseline): change in AFB at 12 months vs. baseline.

Table 2

Change in QOL and symptom severity scores according to presence or absence of atrial fibrillation recurrence >30 s

AllP-valueaRecurrentP-valueaNon-recurrentP-valueaP-valueb
AFEQT(n) Mean ± SD(n) Mean ± SD(n) Mean ± SD
Baseline(225) 55.28 ± 22.78<0.001(120) 51.91 ± 22.35<0.001(93) 59.44 ± 22.76<0.001
12-month(192) 82.93 ± 19.53(110) 75.41 ± 21.75(82) 92.73 ± 9.76
Δ (12 month-Baseline)(189) 27.77 ± 24.13(107) 23.68 ± 24.99(82) 33.09 ± 21.990.008
PCS
Baseline(220) 43.03 ± 11.82<0.001(116) 42.83 ± 12.27<0.001(92) 43.54 ± 11.27<0.001
12-month(192) 49.34 ± 10.16(110) 46.93 ± 11.30(82) 52.58 ± 7.29
Δ (12 month-Baseline)(185) 6.19 ± 11.00(104) 4.09 ± 11.13(81) 8.89 ± 10.300.003
MCS
Baseline(220) 43.67  ± 12.94<0.001(116) 42.34 ± 13.34<0.001(92) 45.21 ± 12.64<0.001
12-month(192) 50.24 ± 11.58(110) 48.20 ± 12.20(82) 52.98 ± 10.15
Δ (12 month-Baseline)(185) 6.78 ± 13.74(104) 5.79 ± 15.25(81) 8.05 ± 11.470.26
CCS-SAF
Baseline(226) 2.30 ± 1.13<0.001(123) 2.35 ± 1.14<0.001(91) 2.22 ± 1.12<0.001
12-month(196) 0.67 ± 1.10(114) 1.11 ± 1.24(82) 0.06 ± 0.36
Δ (12 month-Baseline)(194) −1.60 ± 1.48(113) −1.23 ± 1.59(81) −2.10 ± 1.12<0.001
AllP-valueaRecurrentP-valueaNon-recurrentP-valueaP-valueb
AFEQT(n) Mean ± SD(n) Mean ± SD(n) Mean ± SD
Baseline(225) 55.28 ± 22.78<0.001(120) 51.91 ± 22.35<0.001(93) 59.44 ± 22.76<0.001
12-month(192) 82.93 ± 19.53(110) 75.41 ± 21.75(82) 92.73 ± 9.76
Δ (12 month-Baseline)(189) 27.77 ± 24.13(107) 23.68 ± 24.99(82) 33.09 ± 21.990.008
PCS
Baseline(220) 43.03 ± 11.82<0.001(116) 42.83 ± 12.27<0.001(92) 43.54 ± 11.27<0.001
12-month(192) 49.34 ± 10.16(110) 46.93 ± 11.30(82) 52.58 ± 7.29
Δ (12 month-Baseline)(185) 6.19 ± 11.00(104) 4.09 ± 11.13(81) 8.89 ± 10.300.003
MCS
Baseline(220) 43.67  ± 12.94<0.001(116) 42.34 ± 13.34<0.001(92) 45.21 ± 12.64<0.001
12-month(192) 50.24 ± 11.58(110) 48.20 ± 12.20(82) 52.98 ± 10.15
Δ (12 month-Baseline)(185) 6.78 ± 13.74(104) 5.79 ± 15.25(81) 8.05 ± 11.470.26
CCS-SAF
Baseline(226) 2.30 ± 1.13<0.001(123) 2.35 ± 1.14<0.001(91) 2.22 ± 1.12<0.001
12-month(196) 0.67 ± 1.10(114) 1.11 ± 1.24(82) 0.06 ± 0.36
Δ (12 month-Baseline)(194) −1.60 ± 1.48(113) −1.23 ± 1.59(81) −2.10 ± 1.12<0.001

AFEQT, Atrial Fibrillation Effect on QualiTy-of-life; CCS_SAF, Canadian Cardiovascular Society Severity in Atrial Fibrillation; MCS, mental component score; PCS, physical component score.

a

P-value of difference between baseline and 12-months.

b

P-value of difference between recurrent and non-recurrent.

c

Δ (12 month-baseline): change in AFB at 12 months vs. baseline.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close